Despite a federal judge’s warning against “squabbling with each other,” a fight over leadership has emerged in the multidistrict litigation over Ozempic and related drugs.
Plaintiffs lawyers organized a leadership team of 30 attorneys, including four co-lead counsel: Parvin Aminolroaya, of Seeger Weiss in Ridgefield Park, New Jersey; Jonathan Orent, of Motley Rice in Providence, Rhode Island; Paul Pennock of Morgan & Morgan in New York; and Sarah Ruane, of Wagstaff & Cartmell in Kansas City, Missouri.
